GXO Sets 2030 Targets: >7% Organic Revenue CAGR, >6.5% EBITA Margin, 40-50% FCF Conversion
GXO sits 30% above its 52-week low of $43.61.
Summary
At its Investor Day, GXO introduced 2030 targets of greater than 7% organic revenue CAGR, greater than 6.5% adjusted EBITA margin and 40-50% free cash flow conversion, plus a preliminary 2027 outlook and roughly $1B of buyback capacity through 2030.
Key Events · Earnings and Guidance · GXO
-
2030 Targets Introduced at Investor Day
GXO set 2030 goals of greater than 7% organic revenue CAGR (2027-2030), greater than 6.5% adjusted EBITA margin and 40-50% free cash flow conversion on adjusted EBITDA.
-
Preliminary 2027 Outlook Above 5.5% Growth
Initial 2027 outlook calls for above 5.5% organic revenue growth, greater than 7.1% adjusted EBITDA margin and above 4.5% adjusted EBITA margin, versus a 4.1% adjusted EBITA margin baseline in 2025.
-
$240-310M Four-Year EBITA Savings Plan
Management quantified net run-rate savings of $240-310M by 2030: $70-90M from labor management systems, $50-70M from global procurement, $50-70M from automation and warehouse AI, and $70-80M from other GXO Way levers.
-
~$1B Buyback Capacity Through 2030
Capital allocation framework targets more than $200M a year of share repurchases funded from free cash flow, a ~2.0x net leverage ratio, and repayment of the $275M term loan in the first half of 2027.
Analysis · GXO · Energy & Transportation
GXO used its Investor Day to lay out a four-year financial framework for the first time, and the numbers mark a step up from where the business runs today. The 2030 targets call for greater than 7% organic revenue CAGR from 2027 through 2030, greater than 6.5% adjusted EBITA margin versus a 4.1% 2025 baseline, and 40-50% free cash flow conversion. Bridging the gap is a preliminary 2027 outlook of above 5.5% organic growth and above 4.5% adjusted EBITA margin, while management quantified roughly $240-310M of four-year net EBITA run-rate savings from labor management systems, global procurement, automation/AI and other GXO Way levers. Just as important for holders is the capital allocation piece: about $1B of buyback capacity through 2030 at more than $200M a year, funded from free cash flow, alongside a ~2.0x net leverage target and repayment of the $275M term loan in the first half of 2027. Execution is the risk — the margin bridge leans on self-help savings and a mix shift toward data centers, aerospace and defense and life sciences, and the company has to hit these numbers while carrying a 4.1% starting margin. This lands two weeks after Q3 results that showed 6.4% organic growth and $375M of new business wins, so the targets extend momentum the market has already begun to price.
How filings like this one have moved
In the 30 days to Nov 15, 2026, 37.5% of the 3713 measured filings Wiseek scored 7 moved their stock by 5% or more by the next session's close. The median move was 0.00%. These are measured outcomes after filings of this importance, not a forecast for this one.
Measured one observation per ticker per day, after exclusions. Current figures: Filing Impact Tracker · open dataset
At the time of this filing, GXO was trading at $56.49 on NYSE in the Energy & Transportation sector, with a market capitalization of approximately $6.2B. The 52-week trading range was $43.61 to $66.85. This filing was assessed with positive market sentiment and an importance score of 7 out of 10.